Accounts Receivable, after Allowance for Credit Loss, Current of U S PHYSICAL THERAPY INC /NV from 31 Dec 2014 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
U S PHYSICAL THERAPY INC /NV quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD history and change rate from 31 Dec 2014 to 31 Dec 2025.
  • U S PHYSICAL THERAPY INC /NV Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending 31 Dec 2025 was $64,249,000, a 8.8% increase year-over-year.
Source SEC data
View on sec.gov
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Change (%)

U S PHYSICAL THERAPY INC /NV Quarterly Accounts Receivable, after Allowance for Credit Loss, Current (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $64,249,000 +$5,209,000 +8.8% 31 Dec 2025 10-K 27 Feb 2026 2025 FY
Q3 2025 $67,629,000 +$10,607,000 +19% 30 Sep 2025 10-Q 07 Nov 2025 2025 Q3
Q2 2025 $65,956,000 +$11,297,000 +21% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 $64,760,000 +$9,397,000 +17% 31 Mar 2025 10-Q 09 May 2025 2025 Q1
Q4 2024 $59,040,000 +$7,240,000 +14% 31 Dec 2024 10-K 27 Feb 2026 2025 FY
Q3 2024 $57,022,000 +$4,064,000 +7.7% 30 Sep 2024 10-Q 08 Nov 2024 2024 Q3
Q2 2024 $54,659,000 +$374,000 +0.69% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 $55,363,000 -$1,284,000 -2.3% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 $51,800,000 -$100,000 -0.19% 31 Dec 2023 10-K 27 Feb 2026 2025 FY
Q3 2023 $52,958,000 +$3,211,000 +6.5% 30 Sep 2023 10-Q 08 Nov 2023 2023 Q3
Q2 2023 $54,285,000 +$3,736,000 +7.4% 30 Jun 2023 10-Q 09 Aug 2023 2023 Q2
Q1 2023 $56,647,000 +$7,312,000 +15% 31 Mar 2023 10-Q 05 May 2023 2023 Q1
Q4 2022 $51,900,000 +$5,628,000 +12% 31 Dec 2022 10-K 03 Mar 2025 2024 FY
Q3 2022 $49,747,000 +$3,291,000 +7.1% 30 Sep 2022 10-Q 08 Nov 2022 2022 Q3
Q2 2022 $50,549,000 +$5,405,000 +12% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $49,335,000 +$3,941,000 +8.7% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $46,272,000 +$4,366,000 +10% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 $46,456,000 +$7,017,000 +18% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $45,144,000 +$9,115,000 +25% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $45,394,000 +$2,745,000 +6.4% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $41,906,000 -$4,322,000 -9.3% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $39,439,000 -$7,679,000 -16% 30 Sep 2020 10-Q 06 Nov 2020 2020 Q3
Q2 2020 $36,029,000 -$8,894,000 -20% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 $42,649,000 -$5,794,000 -12% 31 Mar 2020 10-Q 21 May 2020 2020 Q1
Q4 2019 $46,228,000 +$1,477,000 +3.3% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 $47,118,000 +$3,219,000 +7.3% 30 Sep 2019 10-Q 08 Nov 2019 2019 Q3
Q2 2019 $44,923,000 -$501,000 -1.1% 30 Jun 2019 10-Q 09 Aug 2019 2019 Q2
Q1 2019 $48,443,000 +$2,215,000 +4.8% 31 Mar 2019 10-Q 06 May 2019 2019 Q1
Q4 2018 $44,751,000 +$44,000 +0.1% 31 Dec 2018 10-K 28 Feb 2020 2019 FY
Q3 2018 $43,899,000 +$338,000 +0.78% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 $45,424,000 -$1,346,000 -2.9% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 $46,228,000 +$2,984,000 +6.9% 31 Mar 2018 10-Q 07 May 2018 2018 Q1
Q4 2017 $44,707,000 +$5,867,000 +15% 31 Dec 2017 10-K 18 Mar 2019 2018 FY
Q3 2017 $43,561,000 +$5,039,000 +13% 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 $46,770,000 +$7,414,000 +19% 30 Jun 2017 10-Q 07 Aug 2017 2017 Q2
Q1 2017 $43,244,000 +$5,027,000 +13% 31 Mar 2017 10-Q 29 Jun 2017 2017 Q1
Q4 2016 $38,840,000 +$2,609,000 +7.2% 31 Dec 2016 10-K 14 Mar 2018 2017 FY
Q3 2016 $38,522,000 +$3,416,000 +9.7% 30 Sep 2016 10-K 07 Jun 2017 2016 FY
Q2 2016 $39,356,000 +$4,526,000 +13% 30 Jun 2016 10-K 07 Jun 2017 2016 FY
Q1 2016 $38,217,000 +$3,544,000 +10% 31 Mar 2016 10-K 07 Jun 2017 2016 FY
Q4 2015 $36,231,000 +$3,340,000 +10% 31 Dec 2015 10-K 07 Jun 2017 2016 FY
Q3 2015 $35,106,000 30 Sep 2015 10-K 07 Jun 2017 2016 FY
Q2 2015 $34,830,000 30 Jun 2015 10-K 07 Jun 2017 2016 FY
Q1 2015 $34,673,000 31 Mar 2015 10-K 07 Jun 2017 2016 FY
Q4 2014 $32,891,000 31 Dec 2014 10-K 04 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.